Form 4 for LYEL Lyell Immunopharma, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-10 · accession 0001866154-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | 2025-11-10 | LYEL | Hill Stephen J. | COO | S - Sale | $16.12 | -95 | 15.8K | -0.6% | -$1,531 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | S | D | 95 | $16.12 | 15,750 | D | — | — | (F1) Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |